Critical Path Institute ® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.
D., has been welcomed as the new Executive Director of C-Path's Critical Path for Alzheimer's Disease (CPAD) Consortium. With over 30 years of specialized research in neuroscience and drug development and having served as the Executive Director of the Critical Path for Parkinson's Consortium (CPP) for nearly 15 years, Dr.
Stephenson has been an extraordinary partner in advancing our understanding of neurodegenerative diseases such as Alzheimer's (AD), and Parkinson's (PD) diseases. Her leadership in spearheading the progress of CPP through collaboration across all stakeholders has broadened treatment pathways and deepened scientific knowledge in these areas. As Vice President of Neurology, Dr.
Stephenson will continue to guide C-Path's initiatives for brain health, applying her expertise in neuroimaging, neuropathology, digital health technologies and translational model characterization to further C-Path's research objectives. Importantly, she will continue to serve as Executive Director of CPP, ensuring ongoing strategic alignment with C-Path's mission. It is a great privilege to advance my career at C-Path, an organization at the forefront of developing treatments for neurodegenerative diseases.
I am looking forward to this new chapter, where I will continue to build upon our collective expertise a.